Laboratory

Highlight on the DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay

Clinical

Discovers our solutions

PROJET D’OFFRE PUBLIQUE D’ACHAT SIMPLIFIEE VISANT LES ACTIONS DE LA SOCIETE ETABLISSEMENTS FAUVET-GIREL

Nov 10, 2021

Le présent projet de note d’information a été établi et déposé auprès de l’Autorité des marchés financiers (l’« AMF ») le 10 novembre 2021 conformément aux dispositions des articles 231-13, 231-16 et 231-18 de son règlement général. Cette offre et le projet de note d’information restent soumis à l’e…
Read more
ABL Announces Distribution Agreement with Medsol in Saudi Arabia

Nov 02, 2021

Advanced Biological Laboratories (ABL) S.A. and Medsol Corporation are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Saudi Arabia. See current channel partners.
Read more
Acquisition of a controlling stake in ETABLISSEMENTS FAUVET GIREL by ADVANCED BIOLOGICAL LABORATORIES

Oct 18, 2021

Acquisition of a controlling stake in Etablissements Fauvet Girel by Advanced Biological Laboratories ETABLISSEMENTS FAUVET GIREL (the ” Company “) hereby informs its shareholders that STE PARISIENNE DE CONSTRUCTION ET DE LOCATION (SPACLO), holding 91.47% of the Company’s capital,…
Read more

Acquisition du bloc de contrôle de la société ETABLISSEMENTS FAUVET GIREL par la société ADVANCED BIOLOGICAL LABORATORIES SA

Oct 15, 2021

Acquisition du bloc de contrôle de la société Etablissements Fauvet Girel par la société Advanced Biological Laboratories SA La Société ETABLISSEMENTS FAUVET GIREL (la « Société ») informe ses actionnaires que la société STE PARISIENNE DE CONSTRUCTION ET DE LOCATION (SPACLO), détenant 91,47% du capi…
Read more
New Highly Sensitive PCR test (CE IVD) for SARS-CoV-2 detection & confirmation

Oct 11, 2021

For more information please contact us at the following email address: contact@ablsa.com
Read more
ABL Announces Distribution Agreement with BIKO in Uruguay

Sep 29, 2021

Advanced Biological Laboratories (ABL) S.A. and BIKO Uruguay are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Uruguay. See current channel partners.
Read more

Advanced Biological Laboratories Receives CE-IVD Registration for its UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations

Aug 31, 2021

Advanced Biological Laboratories (ABL) announced today the CE-IVD registration of its UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations. Targeting key mutations on the virus, the test helps in this identification of the main variants of concern including lineages Delta and soon Lambda,…
Read more
ABL Announces Distribution Agreement with BIOTECOM in Chile

Aug 24, 2021

Advanced Biological Laboratories (ABL) S.A. and Biotecom S.p.A are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Chile. See current channel partners.
Read more
Two New Distributors

Jul 30, 2021

We are pleased to announce that we entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software: With Integrated Medical Group LLC in Ukraine; and La Sénégalaise des Systèmes Médicaux (SSM) S.A in Senegal. See current channel par…
Read more